Mobia Medical gains Goldman Sachs buy rating as bank sees 130% upside
Fresh from its Nasdaq debut in early May, Mobia Medical is drawing bullish attention as it targets a relatively underserved segment of stroke recovery care. Goldman Sachs starts coverage of the ...